Large-scale genomics research institute advancing disease understanding through sequencing and bioinformatics
The Wellcome Sanger Institute operates a research organization built around genome sequencing and computational biology, running Python, R, and PostgreSQL pipelines against massive genomic datasets. The hiring mix is heavily research-focused (two-thirds of active roles) with embedded data and bioinformatics teams, reflecting their dual challenge: managing rapid dataset growth while automating data curation and annotation at scale. Active projects span clinical sequencing (60k exome cohort), spatial multi-omics atlases, and AI-driven drug target discovery, paired with infrastructure work on storage pipelines and reference genome quality.
Notable leadership hires: Head of Programme
The Wellcome Sanger Institute is a nonprofit genomics research organization headquartered in Hinxton, Cambridgeshire, operating at 1,001–5,000 staff. Funded by the Wellcome Trust, the Institute conducts large-scale genome sequencing and analysis work across human genetics, malaria, cancer, conservation, and disease biology. Their operational scope includes both wet-lab research (CRISPR, PacBio sequencing, organoid work) and computational infrastructure (PostgreSQL/Oracle databases, Linux/Unix clusters, bioinformatics pipelines). They generate and analyze genomic data volumes that are difficult to replicate elsewhere, publishing findings used in translational research and public health.
PacBio sequencing, CRISPR-Cas9 genome editing, Python and R for bioinformatics, PostgreSQL and Oracle for data storage, and GitLab/GitHub for version control across genomics pipelines.
Projects include exome sequencing of 60,000 children, spatial multi-omics atlas construction, generative AI for cell fate prediction, phylogenomics at scale, and open-source translational AI platforms for drug target discovery.
Other companies in the same industry, closest in size